Axsome Therapeutics, Inc. (AXSM)
184.74
+1.44
(+0.79%)
USD |
NASDAQ |
Feb 18, 16:00
184.78
+0.04
(+0.02%)
After-Hours: 20:00
Axsome Therapeutics Total Assets (Quarterly) : 669.25M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 823.61M |
| Gilead Sciences, Inc. | 59.02B |
| Vanda Pharmaceuticals, Inc. | 488.95M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Amicus Therapeutics, Inc. | 868.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 595.52M |
| Shareholders Equity (Quarterly) | 73.73M |
| Debt to Equity Ratio | 2.965 |
| Current Ratio | 1.569 |
| Net Debt Paydown Yield | -0.09% |